Clinical Trial Update: Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing teriparatide with alendronate for glucocorticoid-induced osteoporosis completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)
• Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2009-02-13